DDInter119 DDInter959
Armodafinil is the enantiopure of the wakefulness-promoting agent modafinil (Provigil), and is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD). Research has shown that armodafinil significantly improves driving simulator performance in patients with SWD. Armodafinil consists of the (−)-R-enantiomer of the racemic modafinil. Armodafinil is produced by the pharmaceutical company Cephalon Inc. (a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd.) and was approved by the U.S. Food and Drug Administration (FDA) in June 2007.
Ioflupane (I-123) is a radiopharmaceutical used to image dopamine neurons and diagnose Parkinsonian syndromes.
Ioflupane I-123 {u} (Compound) binds {v} (Gene) SLC6A3
Ioflupane I-123 {u} (Compound) causes {v} (Side Effect) Dysgeusia
Ioflupane I-123 {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Duloxetine
Ioflupane I-123 {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Brexpiprazole
Ioflupane I-123 {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cocaine
Ioflupane I-123 (Compound) binds SLC6A3 (Gene)
Ioflupane I-123 (Compound) causes Dysgeusia (Side Effect)
Ioflupane I-123 may cause a moderate interaction that could exacerbate diseases when taken with Duloxetine
Ioflupane I-123 may cause a moderate interaction that could exacerbate diseases when taken with Brexpiprazole
Ioflupane I-123 (Compound) resembles Cocaine (Compound) and Ioflupane I-123 may cause a moderate interaction that could exacerbate diseases when taken with Cocaine